These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1100898)

  • 1. [Supportive care in bone marrow failure. Technical, immunological and clinical advances].
    Lohrmann HP; Goldmann SF; Adam W
    Klin Wochenschr; 1975 Jul; 53(13):595-603. PubMed ID: 1100898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological studies in patients on platelet- and granulocyte-substitution therapy.
    Pegels JG; Bruynes EC; Engelriet CP; von dem Borne AE
    Br J Haematol; 1982 Sep; 52(1):59-68. PubMed ID: 7115629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates.
    Herzig RH; Herzig GP; Bull MI; Decter JA; Lohrmann HP; Stout FG; Yankee RA; Graw RG
    Blood; 1975 Nov; 46(5):743-50. PubMed ID: 1174708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transfusion alloimmunization to granulocytes and platelets in Japanese patients as determined by the MPHA method.
    Zhang X; Araki N; Ito K
    Transfus Apher Sci; 2001 Dec; 25(3):163-72. PubMed ID: 11846130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of filtration in the provision of leukocyte poor red cells to multitransfused patients.
    James J; Matthews RN; Holdsworth RF; Fulton A; Tauro GP; Hussein S; McGrath KM
    Pathology; 1986 Jan; 18(1):127-30. PubMed ID: 3725421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet component transfusion and alloimmunization: Where do we stand?
    Moncharmont P
    Transfus Clin Biol; 2018 Sep; 25(3):172-178. PubMed ID: 29478960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte transfusion therapy.
    Dutcher JP
    Am J Med Sci; 1984; 287(2):11-7. PubMed ID: 6711583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL-A in connection with blood transfusion.
    Engelfriet CP; van Loghem JJ
    Haematologia (Budap); 1974; 8(1-4):267-72. PubMed ID: 4618231
    [No Abstract]   [Full Text] [Related]  

  • 9. Consequences of prior alloimmunization during granulocyte transfusion.
    Appelbaum FR; Trapani RJ; Graw RG
    Transfusion; 1977; 17(5):460-4. PubMed ID: 910262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet and granulocyte transfusions in cancer patients.
    Dutcher JP
    Adv Immun Cancer Ther; 1986; 2():211-49. PubMed ID: 3321947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Granulocyte and thrombocyte substitution].
    Höcker P; Pittermann E; Mann M; Krasa E; Blumauer H
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):197-203. PubMed ID: 7191415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloimmunization against platelets, granulocytes and erythrocytes in multi-transfused patients in Iranian population.
    Younesi MR; Louni Aligoudarzi S; Bigdeli R; Lashgari M; Mazaheri H; Asgary V
    Transfus Apher Sci; 2016 Oct; 55(2):205-211. PubMed ID: 27318433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The current state of granulocyte transfusion].
    Deubelbeiss KA
    Schweiz Med Wochenschr; 1978 Jul; 108(26):977-80. PubMed ID: 663589
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined granulocyte and platelet transfusions: inter-relationship between granulocyte and platelet recoveries in the presence and absence of complicating factors.
    Ford JM; Cullen MH; Brown LM; Roberts MM; Fulford AJ; Lister TA
    Scand J Haematol; 1984 Jan; 32(1):65-75. PubMed ID: 6582585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion therapy with platelets and leukocytes.
    Luban NL
    Pediatr Ann; 1983 Jun; 12(6):437-44. PubMed ID: 6348681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient platelet and HLA antibody formation in multitransfused patients with malignancy.
    McGrath K; Wolf M; Bishop J; Veale M; Ayberk H; Szer J; Cooper I; Whiteside M
    Br J Haematol; 1988 Mar; 68(3):345-50. PubMed ID: 3355793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood support for the myelosuppressed patient.
    Erickson JM
    Semin Oncol Nurs; 1990 Feb; 6(1):61-6. PubMed ID: 2305134
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic consequences of blood transfusion and their clinical manifestations.
    Petrányi GG; Réti M; Harsányi V; Szabó J
    Int Arch Allergy Immunol; 1997 Dec; 114(4):303-15. PubMed ID: 9414132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-hemolytic transfusion reactions of the febrile type].
    Muñiz Díaz E; Madoz P; Pastoret C; Ercilla G; Roig I; Giro M; Lluch A
    Sangre (Barc); 1990 Feb; 35(1):18-25. PubMed ID: 2333580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.